Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.44 |
| ▸ | BAD | Q92934 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.40 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ALPG | P10696 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1746496 | 1.00 | CDC25B (0.47) | CDC25BATMBCL2L1BADHPGD | |
| SCHEMBL3611155 | 0.95 | SMN1; SMN2 (0.45) | CDC25BATMHPGDSMN1; SMN2MEN1 | |
| SCHEMBL4305925 | 0.87 | ATM (0.53) | CDC25BATMMEN1KMT2ANPSR1 | |
| SCHEMBL4358130 | 0.86 | MAPT (0.56) | CDC25BATMBCL2L1HPGDMEN1 | |
| SCHEMBL4354384 | 0.84 | CDC25B (0.51) | CDC25BATMBCL2L1BADMEN1 | |
| SCHEMBL1637254 | 0.81 | AKR1C3 (0.55) | CDC25BATMMEN1KMT2ANPSR1 | |
| SCHEMBL13444936 | 0.79 | AKR1C3 (0.59) | HPGDSMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL15660414 | 0.78 | SLC6A4 (0.49) | CDC25BATMBCL2L1BADHPGD | |
| SCHEMBL7557424 | 0.77 | NPC1 (0.41) | CDC25BHPGDSMN1; SMN2NPC1MAPT | |
| SCHEMBL1754308 | 0.77 | AKR1C3 (0.58) | CDC25BATMHPGDSMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8952200-B2 | Liquid crystal oligomer, synthesis composition, preparation method thereof, and liquid crystal material | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2015-02-10 | — | — | US | disclosed |
| US-20120264980-A1 | LIQUID CRYSTAL OLIGOMER, SYNTHESIS COMPOSITION, PREPARATION METHOD THEREOF, AND LIQUID CRYSTAL MATERIAL | BEIJING BOE DISPLAY TECHNOLOGY CO., LTD (CN) | 2012-10-18 | — | — | US | disclosed |
| EP-1457511-B1 | CROSSLINKABLE AROMATIC RESINS HAVING PROTONIC ACID GROUPS AND ION CONDUCTIVE POLYMER MEMBRANES BINDERS AND FUEL CELLS MADE BY USING THE SAME | MITSUI CHEMICALS INC (JP) | 2009-07-15 | — | — | EP | disclosed |
| US-20040191602-A1 | Crosslinkable aromatic resin having protonic acid group, and ion conductive polymer membrane, binder and fuel cell using the resin | MITSUI CHEMICALS, INC. (JP) | 2004-09-30 | — | — | US | disclosed |
| EP-1457511-A1 | CROSSLINKABLE AROMATIC RESINS HAVING PROTONIC ACID GROUPS AND ION CONDUCTIVE POLYMER MEMBRANES BINDERS AND FUEL CELLS MADE BY USING THE SAME | Mitsui Chemicals, Inc. (JP) | 2004-09-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264980-A1 | LIQUID CRYSTAL OLIGOMER, SYNTHESIS COMPOSITION, PREPARATION METHOD THEREOF, AND LIQUID CRYSTAL MATERIAL | RNMT, DNMT3A, DNMT1 | CDC25B 1975/4885ATM 1208/4885BCL2L1 1122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.